From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

EXPOSE: Eden Research – something doesn’t add up with TerpeneTech accounts

By Tom Winnifrith, the Sheriff of AIM | Wednesday 17 January 2024

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

At Companies House, Eden Research’s (EDEN) 29.9% associate TerpeneTech has finally published its long delayed accounts for the year ended 31 December 2022 originally due on 30 September 2023. We can now compare the disclosures made with those made by Eden in its accounts for the year ended 31 December 2022 published on 4 May 2023 in respect of TerpeneTech in Note 15. The results are set out below:
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



Video: Poking Bears And Black Swans



Is Stuart Ashman lying again?



So farewell then

Time left: 17:17:53